SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-130772
Filing Date
2017-04-20
Accepted
2017-04-20 17:13:05
Documents
10
Period of Report
2017-06-08
Effectiveness Date
2017-04-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A d360308ddef14a.htm DEF 14A 457882
2 GRAPHIC g360308dsp17.jpg GRAPHIC 55826
3 GRAPHIC g360308pc1.jpg GRAPHIC 239027
4 GRAPHIC g360308pc2.jpg GRAPHIC 145957
5 GRAPHIC g360308pc3.jpg GRAPHIC 113356
6 GRAPHIC g360308pc4.jpg GRAPHIC 143135
7 GRAPHIC g360308stp006a.jpg GRAPHIC 9962
8 GRAPHIC g360308txpg004a.jpg GRAPHIC 1716
9 GRAPHIC g360308txpg004b.jpg GRAPHIC 1043
10 GRAPHIC g360308txpg004c.jpg GRAPHIC 1266
  Complete submission text file 0001193125-17-130772.txt   1440094
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 17773627
SIC: 2834 Pharmaceutical Preparations